Cosmos Health Signs LOI to Acquire Doc Pharma S.A.

Cosmos Health Inc. has entered into a non-binding letter of intent (LOI) to acquire 100% of Doc Pharma S.A., a GMP-licensed European pharmaceutical manufacturer. The proposed deal is intended to deepen Cosmos Health’s vertical integration by expanding manufacturing capacity, product portfolio, and related R&D capabilities, and is expected to be accretive to assets, profitability, and cash flow over time.